Failure to Update Care Plan for Current Psychotropic Medications
Summary
The facility failed to develop and implement a comprehensive care plan that addressed a resident's current psychotropic medication regimen, including individualized interventions and monitoring. The resident was admitted with diagnoses including severe vascular dementia without behavioral disturbance, paroxysmal atrial fibrillation, hypertension, pneumonia, cognitive communication deficit, dysphagia, history of falling, generalized muscle weakness, and anxiety. A baseline MDS showed a BIMS score of 8, indicating moderate cognitive impairment, and the resident was receiving antidepressant medications. The clinical record showed multiple medication changes over time. A physician progress note documented Remeron (mirtazapine) for decreased appetite, with the dose reduced at the daughter's request. A psychiatric note later documented the resident was receiving Remeron 15 mg at bedtime for depression and recommended continuing it without changes. Subsequent physician orders directed staff to monitor for anxiolytic side effects every shift and to complete behavior monitoring every shift for target behaviors such as agitation and calling out, including documentation of non-pharmacological interventions used to redirect the resident. Later orders discontinued Remeron and added Hydroxyzine HCl for anxiety and agitation related to confusion and calling out, Sertraline HCl for depression, and Quetiapine Fumarate for dementia-related behavioral symptoms. The resident's comprehensive care plan, however, still contained a focus for Remeron related to appetite stimulation and insomnia, with interventions to administer the medication as ordered, monitor food intake, and observe for antidepressant side effects. The care plan did not include a focus, goals, or interventions for the resident's current psychotropic medications, including Quetiapine, Sertraline, or Hydroxyzine, and it had not been revised to reflect discontinuation of mirtazapine or initiation of the current medications. Staff interviews confirmed the omission: an LPN stated the current medications were not reflected in the care plan and that the discontinued mirtazapine remained listed, and the Interim DON stated all three psychotropic medications should have been reflected in the care plan.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.